The Institut Pasteur-UCSF QBI Center of Excellence in Emerging Infectious Diseases Seminar Series presents Regis Grailhe, Research Team Leader of the Technology Development Platform at the Institut Pasteur Korea and Professor at the University of Science & Technology.

Dr. Grailhe obtained his PhD from the University Louis Pasteur while conducting his research at Columbia University USA, followed by a Post-Doctorate at the Institut Pasteur France. His research as a group head of the Technology Development Platform focuses on developing optical-based technologies and photonic probes, allowing non-invasive quantification of biological pathways involved in infectious, chronic and chronic diseases.

Dr. Grailhe's research group is at the forefront of developing non-invasive imaging methods by integrating optical-based technologies with fluorescent and luminescent probes. With a keen understanding of the escalating demand for versatile technologies, they specialize in creating straightforward and highly customizable methods that outperform traditional laboratory equipment, all at a fraction of the cost. These methods are tailored to study molecular events occurring across scales, from the nano- to macro-scale, in cells, tissues, and animal models.

In his talk, Dr. Grailhe will unveil his group's latest innovations, which offer unparalleled capabilities for quantifying virus-host protein-protein interactions and tracking inflammatory responses in live cells and animals. These novel technologies not only push the boundaries of what's possible in molecular imaging but also provide invaluable insights into complex biological processes in real-time.

Talk Title: Advancements in Non-Invasive Imaging: Novel Technologies for Quantifying Virus-Host Interactions and Tracking Brain Inflammation